SEC Tracker
Get the app

Kala Bio KALA

The first closing of the Private Placement occurred on November 24, 2025, pursuant

Form
8-K
Filed
Importance
Routine
  • Signs a material agreement (1.01)
  • Sells unregistered shares (3.02)
  • Reports a change in control (5.01)
  • Reports an executive or board change (5.02)
  • Amends its charter or bylaws (5.03)
  • Reports shareholder vote results (5.07)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Kala Bio files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Lexaria Bioscience LEXX public float $25M, Feb 28, 2025, over 18 months old
  2. Aytu Biopharma AYTU public float $24M, Dec 31, 2025
  3. Tenax Therapeutics TENX public float $24M, Jun 30, 2025
  4. Nanoviricides NNVC public float $24M, Dec 31, 2025
  5. Lisata Therapeutics LSTA public float $24M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.